Cellebrite DI Ltd. (CLBT)
| Market Cap | 3.29B -28.8% |
| Revenue (ttm) | 496.43M +18.4% |
| Net Income | 71.35M |
| EPS | 0.28 |
| Shares Out | 249.44M |
| PE Ratio | 47.12 |
| Forward PE | 22.95 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,440,714 |
| Open | 13.30 |
| Previous Close | 13.17 |
| Day's Range | 12.99 - 13.59 |
| 52-Week Range | 11.02 - 19.98 |
| Beta | 1.15 |
| Analysts | Strong Buy |
| Price Target | 21.17 (+60.62%) |
| Earnings Date | May 14, 2026 |
About CLBT
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property thef... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for CLBT stock is "Strong Buy." The 12-month stock price target is $21.17, which is an increase of 60.62% from the latest price.
News
Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth
Cellebrite DI NASDAQ: CLBT executives said the digital investigations company is seeing renewed momentum in government demand, international markets and new product categories, including artificial in...
Cellebrite DI Transcript: J.P. Morgan 54th Annual Global Technology, Media and Communications Conference
Digital intelligence solutions provider reported 21% ARR growth and strong profitability, driven by new AI and cloud products, federal market recovery, and robust international expansion. FedRAMP Level 4 certification and legislative tailwinds position the company for further growth.
Cellebrite price target lowered to $15 from $18 at Needham
Needham lowered the firm’s price target on Cellebrite (CLBT) to $15 from $18 and keeps a Buy rating on the shares. The company’s Q1 results outperformed consensus estimates across the…
Cellebrite DI Q1 Earnings Call Highlights
Cellebrite DI NASDAQ: CLBT reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives high...
Cellebrite reports Q1 non-GAAP EPS 12c, consensus 9c
Reports Q1 revenue $128.3M, consensus $127.03M. “Cellebrite’s (CLBT) Q1 of 2026 was highlighted by the delivery of a substantial slate of innovative offerings and new capabilities to the marketplace,”...
Cellebrite DI Earnings Call Transcript: Q1 2026
Q1 2026 saw 21% ARR growth and 29% higher adjusted EBITDA, driven by strong AI product launches and robust federal and EMEA rebounds. Guidance for Q2 and the full year remains strong, with new products and FedRAMP certification fueling optimism.
Cellebrite DI Earnings release: Q1 2026
Cellebrite DI released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
Cellebrite DI Slides: Q1 2026
Cellebrite DI has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
Cellebrite Announces First-Quarter 2026 Results
First-Quarter ARR Growth of 21% and TTM Free Cash Flow Margin of 32% Q2 Outlook Highlights ARR Acceleration TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 14, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite Announces Participation in Upcoming Investor Conferences
TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 8, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite’s Government Cloud achieves FedRAMP High Authorization
Cellebrite’s (CLBT) Cellebrite Government Cloud, or CGC, platform has achieved FedRAMP High Authorization, the federal government’s highly stringent cloud security standard, with the U.S. Department o...
Cellebrite Government Cloud Achieves FedRAMP High Authorization
Authorization at the highest security standard in the FedRAMP framework enables federal government examiners, investigators, intelligence analysts and field agents to securely collaborate and act on d...
Former Okta President of Auth0, Shiven Ramji, to Join Cellebrite as President, Products and Technology
Ronnen Armon to Retire TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 30, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite to Report First-Quarter 2026 Financial Results on May 14, 2026
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 21, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite Announces 20 JUSTYS Award Winners at C2C User Summit 2026
Hundreds gathered to recognize the best and brightest in digital investigations TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 15, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite Spring Release: New Industry-Leading Device Access and Multi-Cloud Expansion
Now offering access to the widest range of devices and operating systems and expanding availability of Corellium on Google Cloud TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 31, 2026 /PRNewswire/...
Cellebrite Launches Guardian Investigate, the AI-Powered Nerve Center that Revolutionizes How Investigative Teams Close Cases
Investigators and AI agents together resolve cases faster across departments and agencies TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global...
Cellebrite introduced early access to Cellebrite Genesis
Cellebrite (CLBT) introduced early access to Cellebrite Genesis, a new agentic AI product revolutionizing the way investigations get conducted. “Public safety agencies are being asked to do more with ...
Cellebrite Changes the Investigative Game with the Launch of Genesis, the Groundbreaking Agentic AI Solution for Making Our World Safer
Genesis to partner closely with detectives and investigators to convert tasks from weeks to minutes and turn mountains of artifacts into actionable insights TYSONS CORNER, Va. and PETAH TIKVA, Israel,...
Cellebrite Files its 2025 Annual Report on Form 20-F
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 4, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and p...
Cellebrite DI Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026
The company showcased its AI-powered Case-to-Closure platform, emphasizing rapid adoption among state and local governments and expanding use cases in high-profile investigations. Migration to cloud-based products and new acquisitions are driving ARR growth, with guidance for accelerating revenue and strong free cash flow margins.
Cellebrite Completes Acquisition of Drone Forensics Leader SCG Canada, Inc.
Addition of Unmanned Aerial Vehicle (UAV) forensic capabilities extends Cellebrite's AI-powered platform to one of the fastest-growing data sources in defense and public safety TYSONS CORNER, Va. and ...
RDDT, FTNT, CLBT & PLTR to Lead "Rip-Your-Face-Off" Software Rally?
Luke Lloyd isn't buying the Mag 7, arguing that there are far more attractive opportunities, such as software. “We've been buying into this software sell-off the last two or three weeks,” he says, inc...
Cellebrite Announces Participation in the Morgan Stanley Technology, Media & Telecom Conference
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 24, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and p...
Cellebrite price target lowered to $23 from $25 at TD Cowen
TD Cowen lowered the firm’s price target on Cellebrite (CLBT) to $23 from $25 and keeps a Buy rating on the shares. The firm said based on market contraction, they…